前列腺增生症(BPH)是中老年男性的常见病,发病率随年龄增长而增加,50～60岁达50％,60～70岁达70％,70～80岁达80％,81岁以上可达90％以上。虽然BPH很少危及生命,但它可严重影响老年人的生活质量。外科手术治疗(包括开放前列腺切除术和经尿道前列腺切除)仍是目前有效而重要的治疗手段。然而,手术的危险性,手术费用,术后心血管疾病相关的死亡率仍不尽人意。因此,药物治疗BPH受到重视。近年国际上加强了BPH药物治疗的研究,并预测药物治疗是治疗BPH的发展方向。 Prostate hyperplasia (BPH) is a common disease in middle-aged and elderly men, the incidence increases with age, 50 to 60 years of age 50%, 60 to 70 years of age 70%, 70 to 80 years of age 80%, 81 years of age can be More than 90%. Although BPH is rarely life-threatening, it can seriously affect the quality of life of the elderly. Surgical treatment (including open prostatectomy and transurethral resection of the prostate) is still an effective and important treatment. However, the risk of surgery, the cost of surgery, and post-surgical cardiovascular disease-related mortality are still far from satisfactory. Therefore, drug treatment BPH attention. In recent years, the international community has strengthened the study of BPH drug treatment and predicted that drug treatment is the development direction of BPH treatment.